255 related articles for article (PubMed ID: 9170009)
1. Impaired renal haemodynamic response to amino acid infusion in essential hypertension during angiotensin converting enzyme inhibitor treatment.
Tietze IN; Sørensen SS; Ivarsen PR; Nielsen CB; Pedersen EB
J Hypertens; 1997 May; 15(5):551-60. PubMed ID: 9170009
[TBL] [Abstract][Full Text] [Related]
2. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
Eiskjaer H; Nielsen CB; Pedersen EB
J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
[TBL] [Abstract][Full Text] [Related]
3. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
4. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
Komers R; Cooper ME
Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
[TBL] [Abstract][Full Text] [Related]
5. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
Bech JN; Nielsen CB; Pedersen EB
Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
[TBL] [Abstract][Full Text] [Related]
6. Short-term treatment with ramipril normalizes renal haemodynamics and the natriuretic response to a sodium load in type 1 diabetic patients with early nephropathy.
Stenvinkel P; Bolinder J; Alvestrand A
Acta Diabetol; 1997 Mar; 34(1):10-7. PubMed ID: 9134051
[TBL] [Abstract][Full Text] [Related]
7. Renal haemodynamic changes, renal tubular function, sodium and water homeostatic hormones in patients with chronic glomerulonephritis and in healthy humans after intravenous infusion of amino acids.
Tietze IN; Pedersen EB
Nephrol Dial Transplant; 1994; 9(5):499-504. PubMed ID: 8090330
[TBL] [Abstract][Full Text] [Related]
8. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
[TBL] [Abstract][Full Text] [Related]
9. Effect of two regimens of intravenous amino acid infusion on renal haemodynamics, renal tubular function and sodium and water homeostatic hormones in healthy humans.
Sørensen SS; Lauridsen IN; Thomsen K; Pedersen EB
Nephrol Dial Transplant; 1991; 6(6):410-9. PubMed ID: 1876282
[TBL] [Abstract][Full Text] [Related]
10. Effect of ACE inhibition and angiotensin AT1 receptor blockade on renal and blood pressure response to L-arginine in humans.
Komers R; Komersova K; Kazdova L; Ruzickova J; Pelikanova T
J Hypertens; 2000 Jan; 18(1):51-9. PubMed ID: 10678543
[TBL] [Abstract][Full Text] [Related]
11. Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension.
Schmieder RE; Veelken R; Schobel H; Dominiak P; Mann JF; Luft FC
J Am Soc Nephrol; 1997 Jun; 8(6):893-900. PubMed ID: 9189855
[TBL] [Abstract][Full Text] [Related]
12. Effects of captopril on renal function in healthy uninephrectomized subjects and in healthy control subjects.
Nielsen CB; Pedersen EB
J Intern Med; 1994 Apr; 235(4):359-65. PubMed ID: 8151269
[TBL] [Abstract][Full Text] [Related]
13. Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study.
Nielsen CB; Bech JN; Pedersen EB
Br J Clin Pharmacol; 1997 Nov; 44(5):471-6. PubMed ID: 9384464
[TBL] [Abstract][Full Text] [Related]
14. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
[TBL] [Abstract][Full Text] [Related]
15. Systemic and renal haemodynamic effects of angiotensin converting enzyme inhibition by zabicipril in young and in old normal men.
Naeije R; Fiasse A; Carlier E; Opsomer M; Leeman M
Eur J Clin Pharmacol; 1993; 44(1):35-9. PubMed ID: 8436152
[TBL] [Abstract][Full Text] [Related]
16. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
Vervoort G; Hertenberg F; Wetzels JF; Smits P
J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
[TBL] [Abstract][Full Text] [Related]
17. Role of nNOS in regulation of renal function in angiotensin II-induced hypertension.
Cervenka L; Kramer HJ; Malý J; Heller J
Hypertension; 2001 Aug; 38(2):280-5. PubMed ID: 11509490
[TBL] [Abstract][Full Text] [Related]
18. Correlation between glomerular morphology and renal haemodynamic response to amino-acid administration in patients with IgA nephropathy.
Pluvio C; de Pascale E; Giordano M; Cirillo D; Carone M; Pluvio M; Castellino P; Giordano C
Nephrol Dial Transplant; 1996 Dec; 11(12):2421-5. PubMed ID: 9017616
[TBL] [Abstract][Full Text] [Related]
19. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
[TBL] [Abstract][Full Text] [Related]
20. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
